VaxDesign
  • About Us
    • Mission
    • Management
    • Scientific Advisory Board
    • Board of Directors
  • MIMIC® Technology
    • MIMIC® System Overview
    • Blood Collection and Processing
    • Peripheral Tissue Equivalent Module
    • Lymphoid Tissue Equivalent Module
    • Functional Assays and Disease Models
  • MIMIC Applications
    • Applications Overview
    • Vaccine and Adjuvant Immunogenicity
    • Immunotoxicity Predictions
    • Biologic Drug Immunogenicity
    • Vaccine Effectiveness: Clinical Trial in a Test Tube™
  • MIMIC Benefits
    • Benefits Overview
    • Vaccine Assessment
    • Immunotoxicity
    • Biologic Drug Immunogenicity
  • Customers and Collaborators
  • Home
  • News
  • Jobs
  • Donors Program
  • Contact Us

Case Studies

  1. Clinical Trial in a Test Tube™ for Influenza Vaccines
  2. Effect of Immunosuppressants and Immune Stimulants: MIMIC® System Reproduces In Vivo Results
  3. Evaluation of Cross-Reactivity of Influenza Vaccine
  4. Frozen Donor Cells Compared to Fresh Donor Cells
  5. Hepatitis B Vaccine
  6. Immune Suppression by Dexamethasone in MIMIC® System
  7. Lymphoid Tissue Equivalent Module Versus PBMC Assay
  8. MIMIC® Responses to OKT3 versus Avastin®
  9. MIMIC® System Detects Immune Response to Nanoparticles
  10. Peripheral Tissue Equivalent Module Compared to PBMC Assay
  11. Reliability and Reproducibility with Automated MIMIC® Assays
  12. Tetanus Vaccine
  13. Trivalent Inactivated Influenza Vaccine (Fluzone®)
  14. Yellow Fever Vaccine
  • Case Studies
    • Clinical Trial in a Test Tube™ for Influenza Vaccines
    • Effect of Immunosuppressants and Immune Stimulants: MIMIC® System Reproduces In Vivo Results
    • Evaluation of Cross-Reactivity of Influenza Vaccine
    • Frozen Donor Cells Compared to Fresh Donor Cells
    • Hepatitis B Vaccine
    • Immune Suppression by Dexamethasone in MIMIC® System
    • Lymphoid Tissue Equivalent Module Versus PBMC Assay
    • MIMIC® Responses to OKT3 versus Avastin®
    • MIMIC® System Detects Immune Response to Nanoparticles
    • Peripheral Tissue Equivalent Module Compared to PBMC Assay
    • Reliability and Reproducibility with Automated MIMIC® Assays
    • Tetanus Vaccine
    • Trivalent Inactivated Influenza Vaccine (Fluzone®)
    • Yellow Fever Vaccine
 
 
Home | About Us | MIMIC® Technology | MIMIC® Applications | MIMIC® Benefits | Customers and Collaborators
News | Jobs | Donors Program | Contact Us
© 2000-2010 VaxDesign Corporation. All rights reserved. Terms of Use. Privacy Policy.